Delivery Order SPE2DB22D1106-SPE2DB24FFDG2
Award Date
7/22/24
Potential Completion Date
7/23/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of Tobramycin 300 mg/5 ml ampules, a specialty pharmaceutical product, with a total potential value of $2,037.22. The contract has a period of performance through January 26, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,434.99 firm fixed-price delivery order is for the supply of Tobramycin 300 mg/4 ml ampules, a critical antibiotic medication. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $2,633.14 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TOBRAMYCIN 300 MG/5 ML AMPULE UD 5ML, a pharmaceutical product, with a completion date of May 22, 2025. This delivery order is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The order is for 4,559,444,890 units of TOBRAMYCIN 300 MG/5 ML AMPULE, a pharmaceutical product, at a firm fixed price of $1,092.35. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The delivery order, valued at $1,157.19, is for the provision of Tobramycin Pak 300 mg/5 ml, a pharmaceutical product. The delivery order has a firm fixed price structure and a completion date of January 29, 2024. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, as the prime...
This federal contract award is for the delivery of Tobramycin 1.2 GM vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 25, 2025, with a ceiling value of $1,888.72. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a $1,023.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Tobramycin-Dexameth Ophth Susp 5ML, a pharmaceutical product, with a period of performance through May 19, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,972.30, is for the supply of the pharmaceutical product Tobi Podhaler 28 mg inhalation capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $49,112.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The delivery order contract is for the supply of 4,566,026,535 units of the pharmaceutical product TOBI PODHALER 28 MG INHALE CAP UD 56S. The contract has a firm fixed price pricing type and an ultimate completion date of October 7, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,186.01 firm fixed-price delivery order is for the supply of 4562300741 Tobi Podhaler 28 mg inhalation capsules. The contract has a completion date of September 26, 2023 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...